2 weeks Ago By ABMN Staff
StockNews.com assumed coverage on shares of Ekso Bionics ( NASDAQ:EKSO – Free Report ) in a research report sent to investors on Sunday. The brokerage issued a hold rating on the stock.
Other research analysts have also recently issued reports about the stock. HC Wainwright lowered their target price on shares of Ekso Bionics from $10.00 to $9.
00 and set a “buy” rating on the stock in a report on Tuesday, October 29th. Lake Street Capital lowered their price objective on Ekso Bionics from $2.50 to $2.
00 and set a “buy” rating on the stock in a research note on Tuesday, October 29th. Check Out Our Latest Research Report on EKSO Ekso Bionics Stock Performance Ekso Bionics ( NASDAQ:EKSO – Get Free Report ) last announced its earnings results on Monday, October 28th. The company reported ($0.
10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.02).
Ekso Bionics had a negative net margin of 62.95% and a negative return on equity of 83.09%.
The business had revenue of $4.13 million during the quarter, compared to the consensus estimate of $6.00 million.
During the same period in the previous year, the firm posted ($0.24) EPS. Research analysts expect that Ekso Bionics will post -0.
48 EPS for the current year. Institutional Trading of Ekso Bionics A hedge fund recently raised its stake in Ekso Bionics stock. Kent Lake Capital LLC boosted its holdings in shares of Ekso Bionics Holdings, Inc.
( NASDAQ:EKSO – Free Report ) by 322.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 596,050 shares of the company’s stock after purchasing an additional 454,892 shares during the period.
Kent Lake Capital LLC owned about 3.28% of Ekso Bionics worth $811,000 at the end of the most recent quarter. 6.
42% of the stock is currently owned by institutional investors and hedge funds. About Ekso Bionics ( Get Free Report ) Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks.
The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. Featured Articles Receive News & Ratings for Ekso Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics and related companies with MarketBeat.com's FREE daily email newsletter .
.
